Stay updated with breaking news from Kouhei tsumoto. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
~ The development of drugs to treat COVID-19 is accelerating. Of particular interest are drugs that use “neutralizing antibodies” to prevent the virus from multiplying. These antibodies are artificially produced using gene recombination technology, and, when administered to patients, can defend against severe cases of the disease. While this type of drug is already being used in other countries, Japan’s Ministry of Health, Labor and Welfare (MHLW) is expected to approve an “antibody cocktail therapy” developed by United States- and Europe-based pharmaceutical companies and marketed by Chugai Pharmaceutical Co. before the end of July. With seemingly no end to the pandemic in sight, many hope this “wonder drug” will prove to be a game-changer. ....